by app | Oct 1, 2017 | news
News read more Peter Prock becomes non executive director of Nupharm As already reported, APP advised funds controlled by APAX an the acquisition of Inventfarma and Neuraxpharm – the 2 first companies forming Nupharm. Following the creation of...
by app | Sep 27, 2017 | news
News read more Claudio Albrecht becomes interim CEO of Stada AG On September 27, 2017 the Supervisory Board of STADA Arzneimittel AG appointed Dr. Claudio Albrecht as new Chairman of the Executive Board with immediate effect. Dr. Albrecht succeeds...
by app | Apr 1, 2017 | news
News read more APP advises consortium on Stada Funds advised by Bain Capital Private Equity, LP (“Bain Capital”) and by Cinven Partners LLP (“Cinven”), announced the intention to launch a voluntary public takeover offer (the “Takeover Offer”) for all...
by app | Mar 1, 2017 | news
News read more Sean Bowler joins APP We are delighted to announce that Sean Bowler joins APP as Partner. Sean is an engineer who has been Head of Global Engineering and HSE in several major pharmaceutical companies. He has successfully developed and...
by app | Aug 1, 2016 | news
News read more Claudio Albrecht gets appointed as non-executive director of Ino Holdco Ino Holdco S.A.R.L appointed Claudio Albrecht as non-executive Director. Ino Holdco is an entity controlled by APAX Partners and is the holding company of Neuraxpharm,...
